FULC
Price
$7.04
Change
-$0.21 (-2.90%)
Updated
Jun 9, 02:30 PM (EDT)
Capitalization
391.35M
58 days until earnings call
TSBX
Price
$0.37
Change
+$0.01 (+2.78%)
Updated
Jun 9, 03:14 PM (EDT)
Capitalization
8.35M
65 days until earnings call
Interact to see
Advertisement

FULC vs TSBX

Header iconFULC vs TSBX Comparison
Open Charts FULC vs TSBXBanner chart's image
Fulcrum Therapeutics
Price$7.04
Change-$0.21 (-2.90%)
Volume$200
Capitalization391.35M
Turnstone Biologics
Price$0.37
Change+$0.01 (+2.78%)
Volume$2.9K
Capitalization8.35M
FULC vs TSBX Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. TSBX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and TSBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (FULC: $6.90 vs. TSBX: $0.35)
Brand notoriety: FULC and TSBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 178% vs. TSBX: 18%
Market capitalization -- FULC: $391.35M vs. TSBX: $8.35M
FULC [@Biotechnology] is valued at $391.35M. TSBX’s [@Biotechnology] market capitalization is $8.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileTSBX’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • TSBX’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than TSBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while TSBX’s TA Score has 6 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 5 bearish.
  • TSBX’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, TSBX is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а +10.40% price change this week, while TSBX (@Biotechnology) price change was +3.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

TSBX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($391M) has a higher market cap than TSBX($8.35M). FULC YTD gains are higher at: 46.809 vs. TSBX (-30.489). FULC has higher annual earnings (EBITDA): -18.24M vs. TSBX (-76.82M). FULC has more cash in the bank: 241M vs. TSBX (45.3M). TSBX has less debt than FULC: TSBX (1.7M) vs FULC (8.63M). FULC has higher revenues than TSBX: FULC (80M) vs TSBX (0).
FULCTSBXFULC / TSBX
Capitalization391M8.35M4,680%
EBITDA-18.24M-76.82M24%
Gain YTD46.809-30.489-154%
P/E RatioN/AN/A-
Revenue80M0-
Total Cash241M45.3M532%
Total Debt8.63M1.7M508%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCTSBX
RSI
ODDS (%)
Bearish Trend 13 days ago
77%
Bullish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
85%
Bullish Trend 13 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 13 days ago
86%
MACD
ODDS (%)
Bearish Trend 13 days ago
84%
Bullish Trend 13 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
86%
Bearish Trend 13 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
87%
Bearish Trend 13 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
86%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 13 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+8.66%
ANNX - FULC
40%
Loosely correlated
+3.05%
VRDN - FULC
40%
Loosely correlated
-3.09%
RARE - FULC
39%
Loosely correlated
-2.08%
BMRN - FULC
38%
Loosely correlated
-0.03%
PTGX - FULC
37%
Loosely correlated
-1.46%
More

TSBX and

Correlation & Price change

A.I.dvisor tells us that TSBX and CHRS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSBX and CHRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSBX
1D Price
Change %
TSBX100%
+4.00%
CHRS - TSBX
26%
Poorly correlated
+2.54%
ARQT - TSBX
26%
Poorly correlated
-3.96%
LGND - TSBX
25%
Poorly correlated
-1.43%
FULC - TSBX
25%
Poorly correlated
+8.66%
DYN - TSBX
24%
Poorly correlated
+0.51%
More